Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors RFP

Description: This competitive combined synopsis/solicitation seeks medicinal chemistry support for therapeutic development involving the synthesis of HERV-K protease inhibitors. The National Institutes of Health Office of Logistics and Acquisition Operations issued solicitation 75N98026Q00906 for commercial products or commercial services, so it is a procurement solicitation rather than a grant program. Responses are due August 10, 2026, at 9:00 AM, and the notice was issued July 31, 2026.